A Multicenter Trial Enrolling Men With Advanced Prostate Cancer Who Are to Receive Combination Radiation and Sipuleucel-T
Status:
Completed
Trial end date:
2018-06-05
Target enrollment:
Participant gender:
Summary
Radiation in combination with Provenge based immunotherapy may improve outcomes seen on
imaging as well as immunologic monitoring. This study will assess the effect of radiation
therapy to augment anti-tumor responses from immune therapy with Provenge.